|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [665]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [665]
McFarlane, W. R., Lukens, E., Link, B., Dushay, R., Deakins, S. A., Newmark, M., et al. (1995). Multiple family groups and psychoeducation in the treatment of schizophrenia. Archives of General Psychiatry, 52, 679–687.
McGlashan, T. H. (1988). A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophrenia Bulletin, 14, 515–542.
McGlashan, T. H. (1996). Early detection and intervention in schizophrenia: Research. Schizophrenia Bulletin, 22, 327–345.
McGorry, P. D., & Killackey, E. J. (2002). Early intervention in psychosis: A new evidence-based paradigm. Epidemiologia e Psichiatria Sociale, 11, 237–247.
McGorry, P. D., Yung, A. F., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., et al. (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry, 59, 921–928.
McGrath, J. J., van Os, J., Hoyos, C., Jones, P. B., Harvey, I., & Murray, R. M. (1996). Minor physical abnormalities in psychoses: Associations with clinical and putative aetiological variables. Schizophrenia Research, 18, 9–20.
Mednick, S. A., Parnas, J., & Schulsinger, R. (1987). The Copenhagen High-Risk Project. Schizophrenia Bulletin, 13, 485–495.
Mednick, S., & Schulsinger, F. (1968). Some premorbid characteristics related to breakdown in children with schizophrenic mothers. In D. Rosenthal & S. Kety (Eds.), The transmission of schizophrenia (pp. 267–291). Oxford: Pergamon Press.
Meltzer, H. Y., Alphs, L., Green, A. I., Altamura, A. C., Anand, R., Bertoldi, A., et al. (2003). Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Archives of General Psychiatry, 60, 82–91.
Meltzer, H. Y., & Okayli, G. (1995). Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: Impact on risk-benefit assessment. American Journal of Psychiatry, 152, 183–190.
Merlo, M. C., Hofer, H., Gekle, W., Berger, G., Ventura, J., Panhuber, I., et al. (2002). Risperidone, 2 mg/day vs. 4 mg/day, in first-episode, acutely psychotic patients: Treatment efficacy and effects on fine motor functioning. Journal of Clinical Psychiatry, 63, 885–891.
Meyer-Lindenberg, A., Miletich, R. S., Kohn, P. D., Esposito, G., Carson, R. E., Quarantelli, M., et al. (2002). Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nature Neuroscience, 5, 267–271.
Meyer-Lindenberg, A., Poline, J-P., Kohn, P. D., Holt, J. L., Egan, M., Weinberger, D. R., et al. (2001). Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. American Journal of Psychiatry, 158, 1809–1817.
Michie, P., Fox, A., Ward, P., Catts, S., & McConaghy, N. (1990). Event-related potential indices of selective attention and cortical lateralization in schizophrenia. Psychophysiology, 27, 207–227.
Miklowitz, D. J., Goldstein, M. J., Doane, J. A., Nuechterlein, K. H., Strachan, A. M., Snyder, K. S., et al. (1989). Is expressed emotion an index of a transactional process? Relative's affective style. Family Process, 28, 153–167.
Millar, J. K., Wilson-Annan, J. C., Anderson, S., Christie, S., Taylor, M. S., Semple, C. A., et al. (2000). Disruption of two novel genes by a translocation co-segregating with schizophrenia. Human Molecular Genetics, 9, 1415–1423. 
Miller, P., Byrne, M., Hodges, A., Lawrie, S. M., Owens, D. G., & Johnstone, E. C. (2002). Schizotypal components in people at high risk of developing schizophrenia: Early findings from the Edinburgh High-Risk Study. British Journal of Psychiatry, 180, 179–184.
Moises, H. W., Yang, L., Kristbjarnarson, H., Wiese, C., Byerley, W., Macciardi, F., et al. (1995). An international two-stage genome-wide search for schizophrenia susceptibility genes. Nature Genetics, 11, 321–324.
end p.665
|
|
|
|
